New real-world evidence on the MSDA Test published in The Multiple Sclerosis Journal – ET&C. Read the press release.

News & Blog

Catch the latest

Recent Announcements & Press

August 30, 2023

Octave® Bioscience, Inc. Announces Publication of Clinical Validation Study Results of its Novel, Multivariate Multiple Sclerosis Disease Activity (MSDA) Blood Test – Businesswire

August 24, 2023

Octave’s Solution for Transforming the Care Paradigm in MS has been Selected as a Finalist in Fast Company’s 2023 Innovation by Design Awards

July 26, 2023

Octave Bioscience Closes $30M Extension to Series B Funding, Adds New Strategic Investors Following Strong Growth and Momentum – Businesswire

Octave Note

Media Library

Connecting on World MS Day

Octave Bioscience proudly partnered with Olink Proteomics for an in-depth technical webinar featuring Ferhan Qureshi, VP of Biomarker Product Development at Octave, highlighting the importance of creating connections between organizations shaping MS research.

Managing Neurodegenerative Diseases with Better Data to Improve Outcomes

Bill Hagstrom, CEO, spoke to The Bio Report about the Octave's efforts to harness novel measurements of disease to individualize care, the case we're making with payers, and why we're starting with MS.